PetLife Pharmaceuticals, Inc. Shareholders' Equity
PetLife Pharmaceuticals, Inc. had Shareholders' Equity of -$1.97 million as of 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2018-07-17
- 2018-02-28: Stockholders' Equity Attributable to Parent -$1.97M.
- 2017-11-30: Stockholders' Equity Attributable to Parent -$1.77M.
- 2017-08-31: Stockholders' Equity Attributable to Parent -$1.38M.
- 2017-05-31: Stockholders' Equity Attributable to Parent -$1.32M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2018-02-28 | -$1.97M 10-Q · filed 2018-07-17 | |
| 2017-11-30 | -$1.77M 10-Q · filed 2018-01-22 | |
| 2017-08-31 | -$1.38M 10-Q · filed 2018-07-17 | |
| 2017-05-31 | -$1.32M 10-Q · filed 2017-07-18 | |
| 2017-02-28 | -$912.42K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | -$4.15M 10-Q · filed 2017-02-10 | |
| 2016-08-31 | -$3.23M 10-K · filed 2017-12-15 | |
| 2016-05-31 | -$648.82K 10-Q · filed 2016-07-21 | |
| 2016-02-29 | -$524.84K 10-Q · filed 2016-04-19 | |
| 2015-11-30 | -$394.29K 10-Q · filed 2016-01-14 | |
| 2015-08-31 | -$365.13K 10-K · filed 2016-12-21 | |
| 2015-06-30 | -$365.13K 10-K · filed 2017-12-15 | |
| 2015-05-31 | -$351.41K 10-Q · filed 2015-12-31 | |
| 2015-02-28 | -$341.77K 10-Q · filed 2015-12-31 | |
| 2014-11-30 | -$209.04K 10-Q · filed 2015-12-31 | |
| 2014-08-31 | $17.43K 10-K · filed 2016-12-21 | |
| 2014-05-31 | $692.77K 10-Q · filed 2014-08-05 | |
| 2013-11-30 | $700.82K 10-Q · filed 2014-08-05 | |
| 2013-08-31 | $0.00 10-K/A · filed 2016-01-06 | $704.08K 10-K · filed 2014-07-21 |
| 2013-02-28 | $697.60K 10-Q · filed 2014-08-05 | |
| 2012-08-31 | $382.72K 10-K · filed 2014-07-21 | |
| 2012-05-31 | -$15.20K 10-Q · filed 2012-07-23 | |
| 2012-02-28 | -$30.88K 10-Q · filed 2012-04-23 | |
| 2011-11-30 | $65.39K 10-Q/A · filed 2012-01-25 | |
| 2011-08-31 | $307.32K 10-K · filed 2014-07-21 | $307.57K 10-Q/A · filed 2012-01-25 |